STOCK TITAN

Insider plans Rule 144 sale of 15,459 DAWN shares (ticker: DAWN)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of DAWN common stock has filed a notice of proposed sale under Rule 144. The filing covers 15,459 common shares, to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $179,338.31.

The shares are part of a larger base of 102,675,502 shares outstanding and were acquired as restricted stock from the issuer on 02/15/2026. The planned sale date is approximately 02/17/2026 on the NASDAQ exchange.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DAWN Rule 144 filing disclose?

The filing discloses a planned Rule 144 sale of 15,459 common shares of DAWN. These shares, valued at $179,338.31, are to be sold through Morgan Stanley Smith Barney LLC on or around 02/17/2026 on the NASDAQ market.

How many DAWN shares are being proposed for sale under Rule 144?

The notice covers a proposed sale of 15,459 common shares of DAWN. The aggregate market value of this block is listed as $179,338.31, and the transaction is expected to occur via Morgan Stanley Smith Barney LLC’s Executive Financial Services unit.

How large is the planned DAWN sale compared with shares outstanding?

The proposed 15,459-share sale is small relative to 102,675,502 shares outstanding. This means the sale represents only a very small fraction of the company’s total common stock base as disclosed in the filing data.

When and how were the DAWN shares to be sold acquired?

The filing states the 15,459 shares were acquired on 02/15/2026 as restricted stock from the issuer. The nature of payment is described as “Not Applicable,” indicating no separate cash payment terms were detailed for this restricted stock grant.

Who is the broker for the DAWN Rule 144 share sale?

The proposed sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the intended trading venue for the shares is the NASDAQ exchange.

What trading date is indicated for the DAWN Rule 144 transaction?

The filing gives an approximate sale date of 02/17/2026 for the 15,459 DAWN common shares. This date reflects when the holder expects to begin selling the registered shares through Morgan Stanley Smith Barney LLC on the NASDAQ market.
Day One Biopharmaceuticals, Inc.

NASDAQ:DAWN

DAWN Rankings

DAWN Latest News

DAWN Latest SEC Filings

DAWN Stock Data

1.17B
106.76M
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE